Annual report pursuant to Section 13 and 15(d)

9. RELATED PARTY TRANSACTIONS (Details)

v3.19.1
9. RELATED PARTY TRANSACTIONS (Details) - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Sale and purchase of plasma    
Product revenue $ 9,564,388 $ 10,664,456
Purchases 7,822,226 2,776,959
License revenue 142,834 142,834
Interest expense 912,500 520,000
Accounts receivable 961,145 1,245,677
Accounts payable 2,010,774 139,939
Accrued expenses 10,659 314,820
Note payable, net of discount 14,874,184 14,842,396
Accrued interest 65,000 65,000
Deferred revenue $ 2,547,199 $ 2,690,033